Tuesday, March 18th, 2025

Novavax COVID-19 vaccine 89% effective in UK trials


29 January 2021  

Time taken to read : < 1 Minute


  • A
  • A
  • A

LONDON: A new coronavirus vaccine has shown 89.3% efficacy in large-scale UK trials.

The Novavax jab is the first to show it is effective against the new variant of the virus discovered in the UK, BBC reported.

Meanwhile, the UK has secured 60 million doses of the jab, which will be made in Stockton-on-Tees.

The doses are expected to be delivered in the second half of this year, if approved for use by the Medicines and Healthcare Products Regulatory Agency (MHRA), authorities said.

The UK has so far approved three coronavirus vaccines for emergency use – one from Oxford University and AstraZeneca, another by Pfizer and BioNTech, and a third from drug firm Moderna.

(With inputs from BBC)

Publish Date : 29 January 2021 07:25 AM

Today’s news in a nutshell

KATHMANDU: Khabarhub brings you a glimpse of major developments of

NGO Federation of Nepal presents 21-point declaration to PM Oli

KATHMANDU: The newly-elected leadership of the NGO Federation of Nepal

Nava Raj Subedi leaves RPP,  forms new committee with royalist support

KATHMANDU: Nava Raj Subedi, a central working committee member and

Five hydropower projects in Raghuganga commit to address local demands

  MYAGDI: Five hydropower projects under construction in Raghuganga Rural

Deepak Thapa appointed as Inspector General of Police

KATHMANDU: The government has appointed Deepak Thapa as the new